CNBC

Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals (opens in new tab)

Covered by kite.kagi.com

The deals are part of Eli Lilly’s effort to expand into infectious disease research and development.

Read the original article
Sign in to keep reading the full article.
Sign UpLog In

Covered in 1 article

kite.kagi.com·

Eli Lilly plans up to $3.8 billion in vaccine deals

Feeds

Keyboard Shortcuts

Navigation

Next / previous post
j/k
Open post
oorEnter
Preview post
v

Post Actions

Love post
a
Like post
l
Dislike post
d
Undo reaction
u
Save / unsave
s

Recommendations

Add interest / feed
Enter
Not interested
x

Go to

Home
gh
Interests
gi
Feeds
gf
Likes
gl
History
gy
Changelog
gc
Settings
gs
Discover
gb
Search
/

General

Show this help
?
Submit feedback
!
Close modal / unfocus
Esc

Press ? anytime to show this help